COVID 19 and changes in the heart
Not Applicable
- Conditions
- Health Condition 1: J128- Other viral pneumonia
- Registration Number
- CTRI/2020/07/026698
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients screened for COVID infection
Exclusion Criteria
Absence of consent
Patients <18 y of age
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Range and extent of conduction tissue abnormalities due to COVID-19 infection at admission , during admission and at discharge . <br/ ><br>2. Attempts for continuous monitoring shall be made since a point evaluation for the patient <br/ ><br>may not be useful given the varying incidence and transient nature of the cardiovascular manifestationsTimepoint: <br/ ><br>The data shall be collected through out the course of admission of admission of the patients and the algorithm shall be created once we have sufficient patient number to create an algorithm using machine learning and deep learning techniques <br/ ><br>Anticipated time period <br/ ><br>1. Day of admission Day 0 <br/ ><br>2. Day of discharge day 14 <br/ ><br>3. Creation of algorithm : 6months after the enrolment of the last patient
- Secondary Outcome Measures
Name Time Method Echocardiographic Outcomes in Patients with COVID-19 <br/ ><br>Timepoint: 1 year since date of approval;Creation and assessment of artificial intelligence-based ECG Screening tool for the diagnosis and prognosis of the disease <br/ ><br>Timepoint: 1 year since date of approval